ARAV - Aravive, Inc.
IEX Last Trade
0.228
-0.020 -8.947%
Share volume: 6,895,081
Last Updated: Tue 08 Aug 2023 09:59:54 PM CEST
Pharmaceutical Preparation Manufacturing :
2.74%
PREVIOUS CLOSE
CHG
CHG%
$0.25
-0.02
-8.21%
View ratios
Fiscal Date | 2023-03-31 | 2023-06-30 | 2023-09-30 | |
---|---|---|---|---|
Fiscal Quarter | Q1 2023 | Q2 2023 | Q3 2023 | |
Report Date | 2023-05-10 | 2023-08-21 | 2023-11-09 | |
Total revenue | 1.491 M | 1.274 M | 2.756 M | |
Cost of revenue | 0.000 | 0.000 | 0.000 | |
Gross profit | 1.491 M | 1.274 M | 2.756 M | |
-14.55% | 116.33% | |||
Operating expenses | 19.404 M | 13.860 M | 11.670 M | |
Selling general and admin | 3.489 M | 3.070 M | 2.940 M | |
Research and development | 15.915 M | 10.790 M | 8.730 M | |
Total expenses | 19.404 M | 13.860 M | 11.670 M | |
-28.57% | -15.80% | |||
Operating income | -17.913 M | -12.586 M | -8.914 M | |
Ebit | -17.913 M | -12.586 M | -8.914 M | |
Pretax income | -49.956 M | 18.008 M | 21.226 M | |
-136.05% | 17.87% | |||
Income tax | 0.000 | 0.000 | 0.000 | |
Net income basic | -49.956 M | 18.008 M | 21.226 M | |
136.05% | 17.87% | |||
Net income | -49.956 M | 18.008 M | 21.226 M | |
136.05% | 17.87% |